评估1990-2016年疫苗不良事件报告系统(VAERS)中妊娠期乙型肝炎疫苗接种的安全性
研究检索1990年1月1日至2016年6月30日VAERS中妊娠期接种乙型肝炎疫苗的不良事件报告,共192份,其中110份(57.3%)描述不良事件,12份(6.3%)为严重事件,1例新生儿死亡发生于严重早产,无孕产妇死亡。分析未发现新的或非预期的安全信号。
要点
- 192份妊娠期接种乙肝疫苗报告中,110份(57.3%)描述不良事件,12份(6.3%)为严重事件。
- 常见妊娠特异性结局包括自然流产23份、早产7份、选择性终止妊娠5份。
- 22份婴儿不良事件报告中5份描述重大出生缺陷,各累及不同器官系统。
核心结论
- 对VAERS中妊娠期乙型肝炎疫苗接种报告的分析未发现任何新的或非预期的安全关切。
研究设计与样本
- 研究检索VAERS(自发性报告监测系统)1990年1月1日至2016年6月30日涉及妊娠期接种乙型肝炎疫苗的不良事件报告,所有报告及可得病历由医生审阅。
主要发现
- 共发现192份妊娠期接种乙型肝炎疫苗报告,其中110份(57.3%)描述不良事件,12份(6.3%)被分类为严重事件。
- 发现1例新生儿死亡发生于严重早产分娩,无孕产妇死亡;82份(42.7%)报告未描述任何不良事件。
- 在报告孕周的妊娠中,多数于早孕期接种,为86/115(74.7%)。
- 描述不良事件的报告中,最常见妊娠特异性结局为自然流产23份、早产7份、选择性终止妊娠5份;最常见非妊娠特异性结局为一般疾病及给药部位状况(如注射部位和全身反应)21份。
- 在22份描述妊娠期接种后所生婴儿不良事件的报告中,5份描述重大出生缺陷,各累及不同器官系统。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The safety of hepatitis B vaccination during pregnancy has not been well studied. OBJECTIVE: We characterized adverse events (AEs) after hepatitis B vaccination of pregnant women reported to the Vaccine Adverse Event Reporting System (VAERS), a spontaneous reporting surveillance system. METHODS: We searched VAERS for AEs reports involving pregnant women who received hepatitis B vaccine from January 1, 1990-June 30, 2016. All reports and available medical records were reviewed by physicians. Observed AEs were compared to expected AEs and known rates of pregnancy outcomes to assess for any unexpected safety concern. RESULTS: We found 192 reports involving pregnant women following hepatitis B vaccination of which 110 (57.3%) described AEs; 12 (6.3%) were classified as serious; one newborn death was identified in a severely premature delivery, and there were no maternal deaths. Eighty-two (42.7%) reports did not describe any AEs. Among pregnancies for which gestational age was reported, most women were vaccinated during the first trimester, 86/115 (74.7%). Among reports describing an AE, the most common pregnancy-specific outcomes included spontaneous abortion in 23 reports, preterm delivery in 7 reports, and elective termination in 5 reports. The most common non-pregnancy specific outcomes were general disorders and administration site conditions, such as injection site and systemic reactions, in 21 reports. Among 22 reports describing an AE among infants born to women vaccinated during pregnancy, 5 described major birth defects each affecting different organ systems. CONCLUSION: Our analysis of VAERS reports involving hepatitis B vaccination during pregnancy did not identify any new or unexpected safety concerns.
引用
- Moro PL, Zheteyeva Y, Barash F, et al. Assessing the safety of hepatitis B vaccination during pregnancy in the Vaccine Adverse Event Reporting System (VAERS), 1990-2016. Vaccine. 2017. PMID: 29174107. doi:10.1016/j.vaccine.2017.11.039
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。